Synergistic efficacy of combination of enfuvirtide and sifuvirtide, the first- and next-generation HIV-fusion inhibitors
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Immunology,Immunology and Allergy
Reference8 articles.
1. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in north and south America;Lalezari;N Engl J Med,2003
2. Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor;He;J Biol Chem,2008
3. HIV-1 inhibition by a peptide;Jiang;Nature,1993
4. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection;Wild;Proc Natl Acad Sci U S A,1994
5. Rapid emergence of enfuvirtide resistance in HIV-1-infected patients: results of a clonal analysis;Lu;J Acquir Immune Defic Syndr,2006
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Albuvirtide (Aikening), A gp41 Analog as an HIV‐1 Fusion Inhibitor;Current Drug Synthesis;2022-09-22
2. Design and Biological Evaluation of m-Xylene Thioether-Stapled Short Helical Peptides Targeting the HIV-1 gp41 Hexameric Coiled–Coil Fusion Complex;Journal of Medicinal Chemistry;2019-09-12
3. Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41;Viruses;2019-08-01
4. Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBD;Viruses;2019-01-06
5. Enfuvirtide (T20)-Based Lipopeptide Is a Potent HIV-1 Cell Fusion Inhibitor: Implications for Viral Entry and Inhibition;Journal of Virology;2017-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3